Apellis Pharmaceuticals (APLS) Technical (Analysis) Reports Apellis Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Apellis Pharmaceuticals (APLS)
Technical Analysis Report for NASDAQ stock APLS Apellis Pharmaceuticals. Dated: 02 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock APLS Apellis Pharmaceuticals then click here. or read Experts views on Apellis Pharmaceuticals or Forecast & share price targets of Apellis Pharmaceuticals
Apellis Pharmaceuticals Opened at 20.33 and Closed at: 20.70, which is -1.26% of previous session's close. It moved within a range of 20.12 and 21.00
The session was a Bullish session with an average volume of 1625700, which is -15.28% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Dead cross was found 9 days back on short term averages
A Dead cross was found 2 days back on long term averages
Support for tomorrow is 20.41 and resistance for tomorrow is 21.29
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 20.21, 19.73 resistance for tomorrow's hourly charts is 21.09, 21.49
10 Day SMA for Apellis Pharmaceuticals (APLS) is 21.82 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Apellis Pharmaceuticals (APLS) is 22.19 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Apellis Pharmaceuticals (APLS) is 22.99 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 23.07 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Apellis Pharmaceuticals is 22.41 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Apellis Pharmaceuticals is at 22.19 and 200 DMA is at 22.41, while 50 DMA and 100 DMA are at 22.99 and 23.07 respectively
Apellis Pharmaceuticals (APLS) moving average of 20 SMA is at 22.19 and 20 EMA is at 21.98
| Date | Closing Price | 20 SMA | 20 EMA |
| 02 Mon Mar | 20.70 | 22.19 | 21.98 |
| 27 Fri Feb | 20.96 | 22.3 | 22.12 |
| 26 Thu Feb | 21.64 | 22.38 | 22.24 |
| 25 Wed Feb | 21.42 | 22.45 | 22.3 |
| 24 Tue Feb | 22.13 | 22.53 | 22.39 |
| 23 Mon Feb | 22.47 | 22.52 | 22.42 |
Apellis Pharmaceuticals (APLS) moving average of 50 SMA is at 22.99 and 50 EMA is at 22.52
| Date | Closing Price | 50 SMA | 50 EMA |
| 02 Mon Mar | 20.70 | 22.99 | 22.52 |
| 27 Fri Feb | 20.96 | 23.08 | 22.59 |
| 26 Thu Feb | 21.64 | 23.17 | 22.66 |
| 25 Wed Feb | 21.42 | 23.22 | 22.7 |
| 24 Tue Feb | 22.13 | 23.3 | 22.75 |
| 23 Mon Feb | 22.47 | 23.36 | 22.78 |
Apellis Pharmaceuticals (APLS) moving average of 100 SMA is at 23.07 and 100 EMA is at 22.84
| Date | Closing Price | 100 SMA | 100 EMA |
| 02 Mon Mar | 20.70 | 23.07 | 22.84 |
| 27 Fri Feb | 20.96 | 23.12 | 22.88 |
| 26 Thu Feb | 21.64 | 23.15 | 22.92 |
| 25 Wed Feb | 21.42 | 23.17 | 22.95 |
| 24 Tue Feb | 22.13 | 23.19 | 22.98 |
| 23 Mon Feb | 22.47 | 23.2 | 23 |
Apellis Pharmaceuticals (APLS) moving average of 200 SMA is at 22.41 and 200 EMA is at 23.72
| Date | Closing Price | 200 SMA | 200 EMA |
| 02 Mon Mar | 20.70 | 22.41 | 23.72 |
| 27 Fri Feb | 20.96 | 22.39 | 23.75 |
| 26 Thu Feb | 21.64 | 22.38 | 23.78 |
| 25 Wed Feb | 21.42 | 22.36 | 23.8 |
| 24 Tue Feb | 22.13 | 22.34 | 23.82 |
| 23 Mon Feb | 22.47 | 22.32 | 23.84 |
Zai Lab has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Zai Lab, about 23.34% more returns!
Apellis Pharmaceuticals has performed better than Xeris Pharmaceuticals in short term. Holding Apellis Pharmaceuticals could be a better choice for now!
Vericel Corporation has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Vericel Corporation, about 6.54% more returns!
Theravance Biopharma has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Theravance Biopharma, about 6.03% more returns!
Regeneron Pharmaceuticals has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Regeneron Pharmaceuticals, about 15.4% more returns!
Apellis Pharmaceuticals has performed better than Uniqure N in short term. Holding Apellis Pharmaceuticals could be a better choice for now!
Orthofix Medical has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Orthofix Medical, about 13.84% more returns!
Neurocrine Biosciences has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Neurocrine Biosciences, about 6.48% more returns!
Nature S has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Nature S, about 18.77% more returns!
Lipocine Inc has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Lipocine Inc, about 17.1% more returns!
Apellis Pharmaceuticals has performed better than Ac Immune in short term. Holding Apellis Pharmaceuticals could be a better choice for now!
Cerus Corporation has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Cerus Corporation, about 19.35% more returns!
Crispr Therapeutics has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Crispr Therapeutics, about 28.1% more returns!
Edap Tms has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Edap Tms, about 6.58% more returns!
Exelixis Inc has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Exelixis Inc, about 7.57% more returns!
Eyegate Pharmaceuticals has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Eyegate Pharmaceuticals, about 11.45% more returns!
Gilead Sciences has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Gilead Sciences, about 15.94% more returns!
Immuron has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Immuron, about 1.71% more returns!
Apellis Pharmaceuticals Technical analysis of indicators
Price action analysis of Apellis Pharmaceuticals (APLS) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Apellis Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Apellis Pharmaceuticals in short term and the sell signal is strong.
Apellis Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Apellis Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Apellis Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 21.86 and Apellis Pharmaceuticals APLS stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Apellis Pharmaceuticals APLS stock. Volume based technical analysis of Apellis Pharmaceuticals APLS stock is negative.
Apellis Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock APLS Apellis Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And APLS Experts View which covers a lot of information including buying and selling signals
APLS future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Apellis Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Apellis Pharmaceuticals (APLS) Technical (Analysis) Reports Apellis Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


